Medication compliance among patients with
bipolar disorder and substance use disorder
by
Weiss RD, Greenfield SF, Najavits LM,
Soto JA, Wyner D, Tohen M, Griffin ML
Alcohol and Drug Abuse Program,
McLean Hospital,
Belmont, Mass 02178, USA.
J Clin Psychiatry 1998 Apr; 59(4):172-4

ABSTRACT

BACKGROUND: This study examined patterns of medication compliance and reasons for noncompliance among patients with bipolar disorder and substance use disorder. METHOD: Forty-four patients with current bipolar disorder and substance use disorder were administered a structured interview regarding lifetime compliance with prescribed psychotropic medications. RESULTS: Patients who were prescribed both lithium and valproate were significantly (p = .03) more likely to report full compliance with valproate than with lithium. Side effects were the most common reason for lithium noncompliance, but were not cited as a reason for valproate noncompliance. Also, a common pattern of noncompliance among patients prescribed benzodiazepines, neuroleptics, and tricyclic antidepressants was the use of more medication than prescribed. CONCLUSION: Valproate may have greater acceptability than lithium among patients with bipolar disorder and substance use disorder. Clinicians should also be aware that these patients may take higher doses of medication than prescribed.

Mania
Lithium
Valproate
Gabapentin
Lamotrigine
Carbamazepine
Bipolar disorders
Dysphoric hypomania
Valproate for bipolars
Valproate and laughter
Mania: lithium v divalproex
Bipolar treatment guidelines
Valproic acid, valproate and divalproex
Valproate used to treat acute mood episodes
Long-lasting effects of prenatal exposure to valproic acid

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family